(Total Views: 263)
Posted On: 08/02/2019 9:49:57 AM
Post# of 154901
Seems you were spot on:
"Hi. Good to hear from you. Yes, we will provide an update on the colon cancer trials. Although, no decision yet on what level of detail. As a general proposition, however, in any PR we issue, we aim for as much info as we can. Balancing the need to inform our owners (you) and not compromising the chance to publish the data (applies to data in any indication) in a journal or present at a conference. The short answer is, yes. We will disclose as much of the colon cancer data (and all other indications) as we can.
Marek Ciszewski, J.D"
"Hi. Good to hear from you. Yes, we will provide an update on the colon cancer trials. Although, no decision yet on what level of detail. As a general proposition, however, in any PR we issue, we aim for as much info as we can. Balancing the need to inform our owners (you) and not compromising the chance to publish the data (applies to data in any indication) in a journal or present at a conference. The short answer is, yes. We will disclose as much of the colon cancer data (and all other indications) as we can.
Marek Ciszewski, J.D"
(1)
(0)
